We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-12.6%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$323M
AUM Growth
-$70.1M
Cap. Flow
-$12.2M
Cap. Flow %
-3.77%
Top 10 Hldgs %
57.75%
Holding
64
New
17
Increased
10
Reduced
12
Closed
12

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$17M
2
PFE icon
Pfizer
PFE
+$15.9M
3
TFX icon
Teleflex
TFX
+$14.6M
4
TVTX icon
Travere Therapeutics
TVTX
+$12.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$12M

Top Sells

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$26M
2
CI icon
Cigna
CI
+$15.5M
3
AXNX
Axonics, Inc. Common Stock
AXNX
+$8.28M
4
PDCO
Patterson Companies, Inc.
PDCO
+$8.15M
5
HUM icon
Humana
HUM
+$5.81M

Sector Composition

Rank Sector Weight
1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
26
DELISTED
Immunogen Inc
IMGN
$3.69M 1.14%
232,751
-13,170
-5% -$219K
MACK
27
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.56M 1.1%
288,466
-2,283
-0.8% -$27.6K
SVRA icon
28
Savara
SVRA
$1.13B
$3.39M 1.05%
896,250
-114,451
-11% -$408K
ARQT icon
29
Arcutis Biotherapeutics
ARQT
$3.35B
$3.38M 1.05%
635,969
+342,922
+117% +$2.92M
ADCT icon
30
ADC Therapeutics
ADCT
$141M
$2.96M 0.91%
3,294,534
-726,171
-18% -$966K
XFOR icon
31
X4 Pharmaceuticals
XFOR
$390M
$2.83M 0.88%
86,633
+28,333
+49% +$1.24M
RVMD icon
32
Revolution Medicines
RVMD
$41.7B
$2.01M 0.62%
+72,700
New +$2.16M
IDYA icon
33
IDEAYA Biosciences
IDYA
$3.5B
$2M 0.62%
74,007
-587
-0.8% -$14.9K
NYXH
34
Nyxoah
NYXH
$141M
$1.41M 0.44%
200,076
– –
APRE icon
35
Aprea Therapeutics
APRE
$7.8M
$1.17M 0.36%
280,000
– –
PRLD icon
36
Prelude Therapeutics
PRLD
$365M
$1.08M 0.33%
+350,000
New +$1.31M
CRBP icon
37
Corbus Pharmaceuticals
CRBP
$177M
$1.01M 0.31%
150,000
– –
RPTX
38
DELISTED
Repare Therapeutics
RPTX
$919K 0.28%
76,049
– –
SGHT icon
39
Sight Sciences
SGHT
$294M
$831K 0.26%
+246,699
New +$1.62M
MODD icon
40
Modular Medical
MODD
$11.4M
$800K 0.25%
22,978
– –
HARP
41
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$677K 0.21%
+168,017
New +$1.25M
FUSN
42
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$640K 0.2%
246,036
– –
ASLN
43
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$478K 0.15%
31,769
– –
VNDA icon
44
Vanda Pharmaceuticals
VNDA
$310M
$422K 0.13%
97,616
-4,912
-5% -$27.3K
INGN icon
45
Inogen
INGN
$177M
$276K 0.09%
52,794
-58,741
-53% -$417K
NXTC icon
46
NextCure
NXTC
$20.7M
$168K 0.05%
10,833
– –
MBRX icon
47
Moleculin Biotech
MBRX
$2.8M
$116K 0.04%
723
-86
-11% -$17.8K
VINC
48
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$103K 0.03%
5,102
– –
RCKTW icon
49
Rocket Pharmaceuticals Warrant
RCKTW
$310K
$69.8K 0.02%
400,000
– –
CMAX
50
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$65.2K 0.02%
1,025
– –
1
2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sio Capital Management held 64 positions worth $323M, down 18% from $393M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sio Capital Management withdrew a net $12.2M in Q3 2023, closing 12 positions and reducing 12 holdings. Its most notable exit was Axonics, Inc. Common Stock, an estimated $8.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 71% a quarter earlier.

Against the trend, Sio Capital Management opened a new position in Pfizer worth $14.9M.

  • Sio Capital Management's largest Q3 2023 buy was Pfizer: 450,700 shares worth $14.9M.
  • Sio Capital Management added most to Globus Medical in Q3 2023, an estimated $17M increase.
  • Sio Capital Management's biggest Q3 2023 reduction was GE HealthCare, cutting an estimated $26M.
  • Sio Capital Management fully exited Axonics, Inc. Common Stock in Q3 2023, selling an estimated $8.28M.
  • Sio Capital Management's ten largest holdings make up 58% of its $323M portfolio in Q3 2023.
  • Sio Capital Management opened 17 new positions and closed 12 in Q3 2023.
  • Sio Capital Management's portfolio value fell 18% quarter-over-quarter to $323M.

Based on Sio Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.